Cargando…

The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer

Endocrine therapy is the prominent strategy for the treatment of hormone-positive breast cancers. The emergence of resistance to endocrine therapy is a major health concern among hormone-positive breast cancer patients. Resistance to endocrine therapy demands the design of newer therapeutic strategi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Jie, Yang, Li, Li, Zhi, Zhang, Hua, Wang, Qun, Huang, Jun, Wang, Bei, Mohan, Chakrabhavi Dhananjaya, Sethi, Gautam, Wang, Geng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611521/ https://www.ncbi.nlm.nih.gov/pubmed/37900137 http://dx.doi.org/10.3389/fendo.2023.1261283

Ejemplares similares

The Role of Ki67 in Evaluating Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer
por: Zhang, Ailin, et al.
Publicado: (2021)

Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
por: Rani, Aradhana, et al.
Publicado: (2019)

Aging under endocrine hormone regulation
por: Xing, Yutong, et al.
Publicado: (2023)

Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer
por: Belachew, Esmael Besufikad, et al.
Publicado: (2021)

The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer
por: Diaz Bessone, María Inés, et al.
Publicado: (2019)

Corrigendum: Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer
por: Belachew, Esmael Besufikad, et al.
Publicado: (2021)

Editorial: Further advances in understanding the endocrine cancer microenvironment
por: Coperchini, Francesca, et al.
Publicado: (2022)

The Environmental Pollutant Bromophenols Interfere With Sulfotransferase That Mediates Endocrine Hormones
por: Dai, Zhihong, et al.
Publicado: (2022)

Endocrine Disruption of the Follicle-Stimulating Hormone Receptor Signaling During the Human Antral Follicle Growth
por: Roy, Neena, et al.
Publicado: (2021)

The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders
por: Bertoldo, Eugenia, et al.
Publicado: (2021)

Editorial: Placental Hormones and Pregnancy-Related Endocrine Disorders
por: Zhou, Qiongjie, et al.
Publicado: (2022)

Clinicopathological characteristics, evolution, treatment pattern and outcomes of hormone-receptor-positive/HER2-low metastatic breast cancer
por: You, Shuhui, et al.
Publicado: (2023)

Editorial: Hormone Action and Signal Transduction in Endocrine Physiology and Disease
por: Balla, Tamas, et al.
Publicado: (2020)

Single Hormone Receptor-Positive Metaplastic Breast Cancer: Similar Outcome as Triple-Negative Subtype
por: Mao, Jinqian, et al.
Publicado: (2021)

Editorial: Estrogen receptors in endocrine disorders
por: Filardi, Tiziana, et al.
Publicado: (2023)

Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma
por: Lee, Jong Hyun, et al.
Publicado: (2019)

The immune microenvironment characterisation and dynamics in hormone receptor–positive breast cancer before and after neoadjuvant endocrine therapy
por: Oner, Gizem, et al.
Publicado: (2023)

Editorial: The Role of Exosomes in Metabolic and Endocrine Disease
por: Guo, Bei, et al.
Publicado: (2022)

Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas
por: Moin, Abu Saleh Md, et al.
Publicado: (2019)

A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions
por: Emanuel, Rebecca H. K., et al.
Publicado: (2022)

Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors
por: Bianchi, Antonio, et al.
Publicado: (2023)

Editorial: The liver as an endocrine organ: Hepatokines and ketone bodies, novel hormones to be acknowledged
por: Risi, Renata, et al.
Publicado: (2023)

Progress in salivary glands: Endocrine glands with immune functions
por: Shang, Yu Feng, et al.
Publicado: (2023)

Euphorbiasteroid Abrogates EGFR and Wnt/β-Catenin Signaling in Non-Small-Cell Lung Cancer Cells to Impart Anticancer Activity
por: Kim, Na Young, et al.
Publicado: (2022)

GPER as a Receptor for Endocrine-Disrupting Chemicals (EDCs)
por: Périan, Séverine, et al.
Publicado: (2020)

Editorial: The role of exosomes and organokines in metabolic and endocrine disease
por: Wang, Qi-Yu, et al.
Publicado: (2023)

Editorial: Hormone Receptors and Breast Cancer
por: Brunetti, Antonio, et al.
Publicado: (2019)

Editorial: Hormones and receptors in breast cancer
por: Rosemblit, Cinthia, et al.
Publicado: (2023)

Role of Hydrogen Sulfide in the Endocrine System
por: Chen, Hao-Jie, et al.
Publicado: (2021)

Role of SST, CORT and ghrelin and its receptors at the endocrine pancreas
por: Beléen, Chanclón, et al.
Publicado: (2012)

Obesity and endocrine-related cancer: The important role of IGF-1
por: Zhong, Wentao, et al.
Publicado: (2023)

Endocrine Disrupting Chemicals: Effects on Endocrine Glands
por: Lauretta, Rosa, et al.
Publicado: (2019)

Endocrine Disrupting Chemicals Interfere With Leydig Cell Hormone Pathways During Testicular Descent in Idiopathic Cryptorchidism
por: Fénichel, Patrick, et al.
Publicado: (2019)

Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
por: D’Souza, Anishka, et al.
Publicado: (2018)

Endocrine disrupting and carcinogenic effects of decabromodiphenyl ether
por: Wang, Yi, et al.
Publicado: (2023)

The Role of Endocrine G Protein-Coupled Receptors in Ovarian Cancer Progression
por: Zhang, Qingyu, et al.
Publicado: (2017)

Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
por: Bian, Li, et al.
Publicado: (2020)

Analysis of risk factors for positive surgical margin after laparoscopic radical prostatectomy with and without neoadjuvant hormonal therapy
por: Wang, Fangming, et al.
Publicado: (2023)

Clinicopathological characteristics and prognostic analysis of breast cancer with a hormone receptor status of ER(-)/PR(+)
por: Wang, Xinli, et al.
Publicado: (2023)

Periprostatic Adipose Tissue Microenvironment: Metabolic and Hormonal Pathways During Prostate Cancer Progression
por: Sacca, Paula Alejandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aqe1td2epommjms6p52cu3i85p